ABEO
NASDAQ · Biotechnology
Abeona Therapeutics Inc
$5.13
+0.23 (+4.69%)
Open$4.99
Previous Close$4.90
Day High$5.16
Day Low$4.93
52W High$15.27
52W Low$9.89
Volume—
Avg Volume280.1K
Market Cap278.00M
P/E Ratio53.84
EPS$0.20
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+174.7% upside
Current
$5.13
$5.13
Target
$14.09
$14.09
$7.81
$14.09 avg
$15.42
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 42.03M | 39.71M | 32.89M |
| Net Income | -4,956,318 | -4,431,314 | -3,676,832 |
| Profit Margin | -11.8% | -11.2% | -11.2% |
| EBITDA | -5,373,900 | -4,969,444 | -4,544,257 |
| Free Cash Flow | -5,460,500 | -4,447,710 | -3,857,678 |
| Rev Growth | +0.4% | +12.5% | +7.0% |
| Debt/Equity | 0.19 | 0.22 | 0.21 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |